As the industry shifts to value-based care, proactive intervention programs designed to address chronic conditions and social determinants of health are rapidly becoming critical investments for care improvement and cost reduction. Unfortunately, the vast majority of these programs lack evidence to prove their effectiveness, and healthcare organizations (HCOs) can’t afford to invest in unmeasurable intervention programs.
Read the paper to learn: